MOYOM Secures EU-MDR Certification for APHRANEL, Forms Scientific Alliance
Biotechnology firm MOYOM announced it has received EU Medical Device Regulation (EU-MDR) certification for its product APHRANEL. The company also established a strategic scientific collaboration with Expert2Expert.
Biotechnology company MOYOM has achieved certification under the European Union's Medical Device Regulation (EU-MDR) for its product, APHRANEL. This certification represents a significant step in the company's European market strategy.
In parallel, MOYOM has initiated a strategic scientific collaboration with the Expert2Expert network. This partnership aims to deepen the company's focus on regenerative aesthetics by leveraging the expertise of leading industry specialists.
The EU-MDR certification validates the safety and efficacy of APHRANEL for the European market, facilitating broader access and clinical application.
The collaboration with Expert2Expert is expected to drive further research and product development, reinforcing MOYOM's position in the field of regenerative aesthetics.